Showing results (211-220 of 330) with videos related to
Sort By:
Pageof 33
JACC. Cardiooncology|November 29, 2022
Cellular and Molecular Mechanisms of MEK1 Inhibitor-Induced CardiotoxicityTyler C Beck, Dimitrios C Arhontoulis, Jordan E Morningstar, et al.JACC. Cardiooncology|December 2, 2020
Cardiology Involvement in Patients with Breast Cancer Treated with TrastuzumabBiniyam G Demissei, Srinath Adusumalli, Rebecca A Hubbard, et al.JACC. Cardiooncology|March 6, 2023
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-UpMelinda A Pruis, G D Marijn Veerman, H Carlijne Hassing, et al.JACC. Cardiooncology|March 6, 2023
Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma PatientsJulius C Heemelaar, Frank M Speetjens, Ahmed A M Al Jaff, et al.JACC. Cardiooncology|March 5, 2025
Cardiac Effects of Modern Breast Radiation Therapy in Patients Receiving Systemic Cancer TherapyEva Berlin, Kyunga Ko, Lin Ma, et al.JACC. Cardiooncology|February 19, 2025
SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial EnergeticsDanielle Medina-Hernández, Laura Cádiz, Annalaura Mastrangelo, et al.JACC. Cardiooncology|February 19, 2025
Atorvastatin and Myocardial Extracellular Volume Expansion During Anthracycline-Based ChemotherapyVencel Juhasz, Thiago Quinaglia, Zsofia D Drobni, et al.JACC. Cardiooncology|October 31, 2024
Life's Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast CancerElena Wadden, Alexi Vasbinder, Vidhushei Yogeswaran, et al.JACC. Cardiooncology|October 31, 2024
Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence: A Cardio-Oncology ApproachArce Domingo-Relloso, Angela L Riffo-Campos, Naisi Zhao, et al.JACC. Cardiooncology|September 6, 2024
Predictive Performance of Cardiovascular Risk Scores in Cancer Survivors From the UK BiobankCeleste McCracken, Dorina-Gabriela Condurache, Liliana Szabo, et al.Pageof 33